Hearing Loss Genetics tests in Dubai & UAE

Compare available Hearing Loss Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Hearing Loss Genetics test prices

Showing 1–15 of 20 matching tests.

Hearing Loss Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5721 CDH23 Gene Deafness, Autosomal Recessive Type 12 (DFNB12) Genetic Test This genetic test analyzes the CDH23 gene to identify pathogenic variants associated with autosomal recessive non-syndromic hearing loss type 12 (DFNB12).	Peripheral Whole Blood (EDTA Tube) or FTA Card Spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CDH23 gene sequence", "Pathogenic variants in coding exons, splice junctions, and deep intronic regions"] Parameters [] Preparation ["No fasting required.", "Stay well-hydrated."] Indications ["Diagnosis of suspected DFNB12", "Carrier screening for CDH23 variants", "Premarital counselling", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: H90.3 Clinical summary This genetic test analyzes the CDH23 gene to identify pathogenic variants associated with autosomal recessive non-syndromic hearing loss type 12 (DFNB12).
TEST-5663 DCDC2 Gene (Autosomal Recessive Deafness Type 66) Genetic Test This test identifies pathogenic variants in the DCDC2 gene associated with autosomal recessive non-syndromic hearing loss (DFNB66).	Whole blood (EDTA), extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DCDC2 gene", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation ["Submit detailed clinical history and audiogram prior to sample collection.", "Inform phlebotomist if taking high-dose biotin (>5 mg/day) – an 8-hour washout is advised.", "Do not discontinue prescribed medications, hearing aids, or cochlear implant programming without consulting your clinician."] Indications ["Diagnosis of autosomal recessive non-syndromic hearing loss (DFNB66)", "Carrier screening for at-risk family members", "Pre-implantation genetic diagnosis (PGD) or prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: H90.5 Clinical summary This test identifies pathogenic variants in the DCDC2 gene associated with autosomal recessive non-syndromic hearing loss (DFNB66).
TEST-5722 DIAPH1 Gene (Deafness, Autosomal Dominant 1) Genetic Test This genetic test identifies pathogenic variants in the DIAPH1 gene associated with autosomal dominant non-syndromic hearing loss (DFNA1). It analyzes the entire coding sequence an...	Whole Blood (EDTA), Extracted DNA, or Dry Blood Spot on FTA Card	3 to 4 Weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DIAPH1 gene", "Coding regions and splice sites of DIAPH1"] Parameters [] Preparation [] Indications ["Individuals with clinical suspicion of hereditary hearing loss", "Family history of DFNA1", "Need for genetic counselling and family planning"] Measurement technique Confirm with laboratory Codes LOINC: 94121-2 ICD-10: H90.5 Clinical summary This genetic test identifies pathogenic variants in the DIAPH1 gene associated with autosomal dominant non-syndromic hearing loss (DFNA1). It analyzes the entire coding sequence and splice sites of the gene.
TEST-5687 ESRRB Gene Deafness (Autosomal Recessive Type 35) Genetic Test This genetic test identifies pathogenic variants in the ESRRB gene associated with autosomal recessive deafness type 35.	Whole blood (EDTA), extracted DNA, or FTA card (dried blood spot)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ESRRB gene"] Parameters [] Preparation ["No fasting, medication hold, or special preparation required.", "A genetic counselling session is advised prior to testing."] Indications ["Individuals with congenital or early-onset non-syndromic sensorineural hearing loss", "Family history suggesting recessive inheritance", "Relatives seeking carrier status for reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 97163-3 ICD-10: H90.3 Clinical summary This genetic test identifies pathogenic variants in the ESRRB gene associated with autosomal recessive deafness type 35.
TEST-5780 EYA4 Gene (DFNA10) Autosomal Dominant Hearing Loss Genetic Test (NGS) This test detects pathogenic variants in the EYA4 gene associated with autosomal dominant nonsyndromic sensorineural hearing loss.	Whole blood (EDTA), dried blood spot (FTA card), or extracted DNA	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the EYA4 gene", "Autosomal dominant inheritance patterns"] Parameters [] Preparation ["No dietary or medication adjustments needed", "Inform phlebotomist if on anticoagulants"] Indications ["Progressive post-lingual hearing deterioration", "Family history of similar deafness"] Measurement technique Confirm with laboratory Codes LOINC: 94513-5 ICD-10: H90.5 Clinical summary This test detects pathogenic variants in the EYA4 gene associated with autosomal dominant nonsyndromic sensorineural hearing loss.
TEST-5714 GJB2 Gene Deafness, Autosomal Recessive Type 1A Genetic Test This diagnostic test evaluates the GJB2 gene for mutations associated with autosomal recessive deafness type 1A.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GJB2 gene sequence", "Point mutations", "Insertions/Deletions (Indels)", "Copy Number Variations (CNVs)"] Parameters [] Preparation ["Genetic counselling session required prior to testing", "Provide a detailed family history and pedigree chart"] Indications ["Diagnosis of autosomal recessive deafness type 1A (DFNB1A)", "Individuals with congenital or early-onset hearing loss", "Families with a history of early-onset deafness", "Couples planning pregnancy with a family history of hearing loss"] Measurement technique Confirm with laboratory Codes LOINC: 60674-4 ICD-10: H90.3 Clinical summary This diagnostic test evaluates the GJB2 gene for mutations associated with autosomal recessive deafness type 1A.
TEST-5651 GJB6 Gene Deafness, Autosomal Recessive Type 1B Genetic Test This test analyzes the GJB6 gene for mutations associated with autosomal recessive sensorineural hearing loss.	Whole Blood, Extracted DNA, Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GJB6 gene mutations", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variations (CNV >15 bp)"] Parameters [] Preparation ["No fasting required", "No special preparation needed"] Indications ["Newborns and children with bilateral sensorineural hearing loss, especially when GJB2 testing is negative", "Adults with late-onset hearing loss suspected to have a genetic origin"] Measurement technique Confirm with laboratory Codes LOINC: 21651-9 ICD-10: H90.3 Clinical summary This test analyzes the GJB6 gene for mutations associated with autosomal recessive sensorineural hearing loss.
TEST-5700 GRXCR1 Gene NGS Test for Autosomal Recessive Deafness Type 25 (DFNB25) This test identifies pathogenic variants in the GRXCR1 gene associated with autosomal recessive nonsyndromic hearing loss DFNB25.	Peripheral whole blood (EDTA tube)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GRXCR1 gene"] Parameters [] Preparation [] Indications ["Suspected autosomal recessive nonsyndromic hearing loss DFNB25", "Carrier screening for family members"] Measurement technique Confirm with laboratory Codes LOINC: 55324-5 ICD-10: H90.3 Clinical summary This test identifies pathogenic variants in the GRXCR1 gene associated with autosomal recessive nonsyndromic hearing loss DFNB25.
TEST-5738 GSDME (DFNA5) Gene NGS Sequencing for Autosomal Dominant Deafness Type 5 Test This test identifies pathogenic variants in the GSDME gene associated with autosomal dominant non-syndromic hearing loss.	Peripheral Whole Blood (EDTA) or Buccal Swab / Saliva	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GSDME gene"] Parameters [] Preparation ["No fasting required", "No medication adjustments needed"] Indications ["Individuals with progressive sensorineural hearing loss and a strong family history of deafness", "Asymptomatic at-risk relatives seeking clarity"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: H90.5 Clinical summary This test identifies pathogenic variants in the GSDME gene associated with autosomal dominant non-syndromic hearing loss.
TEST-5699 KCNQ4 Gene Sequencing (Autosomal Dominant Deafness Type 2A, DFNA2A) Test This diagnostic test evaluates the KCNQ4 gene for pathogenic variants associated with autosomal dominant nonsyndromic sensorineural hearing loss type 2A (DFNA2A).	Peripheral Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the KCNQ4 gene", "Coding exons and flanking intronic regions of KCNQ4"] Parameters [] Preparation ["No specific fasting required", "Inform the lab of any history of ototoxic medication exposure or head trauma"] Indications ["Suspected hereditary hearing loss pattern consistent with DFNA2A", "Genetic counseling for families with DFNA2A"] Measurement technique Confirm with laboratory Codes LOINC: 81327-2 ICD-10: H90.3 Clinical summary This diagnostic test evaluates the KCNQ4 gene for pathogenic variants associated with autosomal dominant nonsyndromic sensorineural hearing loss type 2A (DFNA2A).
TEST-5472 MITF Gene Tietz Albinism‑Deafness Syndrome Genetic Test This genetic test evaluates the MITF gene for pathogenic variants associated with Tietz syndrome.	Whole blood, extracted DNA, or dried blood spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MITF gene"] Parameters [] Preparation [] Indications ["Individuals with unexplained congenital hearing loss and albinism", "Positive family history of Tietz syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 81438-1 ICD-10: Q87.8 Clinical summary This genetic test evaluates the MITF gene for pathogenic variants associated with Tietz syndrome.
TEST-5710 MYH9 Gene (DFNA17) Autosomal Dominant Nonsyndromic Hearing Loss — Genetic Test This test identifies pathogenic variants within the MYH9 gene associated with autosomal dominant nonsyndromic hearing loss (DFNA17). It uses Next-Generation Sequencing (NGS) with S...	Peripheral blood, DNA, FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MYH9 gene coding region"] Parameters [] Preparation ["No fasting required", "No medication adjustments required"] Indications ["Individuals with documented sensorineural hearing loss", "Individuals with a family history consistent with DFNA17", "Diagnostic confirmation of DFNA17"] Measurement technique Confirm with laboratory Codes LOINC: 60591-5 ICD-10: H90.5 Clinical summary This test identifies pathogenic variants within the MYH9 gene associated with autosomal dominant nonsyndromic hearing loss (DFNA17). It uses Next-Generation Sequencing (NGS) with Sanger confirmation.
TEST-5709 MYO7A Gene (Deafness, Autosomal Recessive Type 2) Genetic Test This genetic test evaluates the MYO7A gene for pathogenic variants associated with autosomal recessive deafness type 2 (DFNB2) and Usher syndrome type 1B.	Whole Blood (EDTA Tube), Extracted DNA, or FTA Card Blood Spot	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MYO7A gene", "Copy Number Variations (CNVs) in MYO7A"] Parameters [] Preparation ["No specific fasting required.", "Inform the lab of any relevant family history of hearing loss."] Indications ["Diagnosis of autosomal recessive deafness type 2 (DFNB2)", "Diagnosis of Usher syndrome type 1B", "Genetic counselling for families with hearing loss"] Measurement technique Confirm with laboratory Codes LOINC: 21656-9 ICD-10: H90.3, H90.5 Clinical summary This genetic test evaluates the MYO7A gene for pathogenic variants associated with autosomal recessive deafness type 2 (DFNB2) and Usher syndrome type 1B.
TEST-5649 OTOA Gene Deafness, Autosomal Recessive Type 22 Genetic Test This test detects pathogenic variants in the OTOA gene associated with autosomal recessive nonsyndromic sensorineural hearing loss type 22.	Peripheral Whole Blood (EDTA) or Buccal Swab	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the OTOA gene"] Parameters [] Preparation [] Indications ["Individuals with congenital or prelingual bilateral hearing loss of unknown cause", "Family history suggesting recessive inheritance"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: H90.3 Clinical summary This test detects pathogenic variants in the OTOA gene associated with autosomal recessive nonsyndromic sensorineural hearing loss type 22.
TEST-5676 POU4F3 Gene (Autosomal Dominant Deafness Type 52) Genetic Test This test detects pathogenic variants in the POU4F3 gene associated with autosomal dominant non-syndromic hearing loss (DFNA52). It uses next-generation sequencing and Sanger confi...	Whole Blood, Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the POU4F3 gene", "Presence of mutations causing DFNA52"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any current medications"] Indications ["Diagnosis of autosomal dominant non-syndromic hearing loss (DFNA52)", "Genetic counselling for families with hearing loss", "Risk assessment for family members"] Measurement technique Confirm with laboratory Codes LOINC: 94121-4 ICD-10: H90.3 Clinical summary This test detects pathogenic variants in the POU4F3 gene associated with autosomal dominant non-syndromic hearing loss (DFNA52). It uses next-generation sequencing and Sanger confirmation for high accuracy.

Category overview

Hearing Loss Genetics: overview

Understanding the broader hereditary landscape of auditory health empowers you to make fully informed, proactive decisions for your child’s developmental future. Integrated into our advanced Genetics department, comprehensive Hearing Loss Genetics screening utilizes expansive panels to simultaneously evaluate dozens of genes linked to both syndromic and non-syndromic deafness. Utilizing state-of-the-art genomic profiling, this robust screening uncovers elusive genetic drivers, offering the exact clarity required to safely guide specialized multidisciplinary care, proactive vision or thyroid monitoring (for syndromic cases like Usher or Pendred syndromes), and customized early intervention therapies. Highly regarded for clinical excellence among diagnostic labs in Dubai and the UAE, DNA Labs guarantees absolute patient confidentiality, exceptional analytical precision, and remarkably fast turnaround times. Take an empowered step toward targeted support—schedule your hearing loss genetics testing in UAE, coordinate a secure clinical sample collection, or consult our expert medical team.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.